Nanobiotix SA Sustainability Reports
Nanobiotix S.A. is a clinical-stage biotechnology company that develops physics-based therapeutic nanoparticles designed to safely enhance the efficacy of radiation therapy in oncology. The company aims to improve cancer treatment outcomes at the cellular level across various solid tumor indications.
Sector: Professional & technical services
Country: France
Exchange: Euronext Paris
LEI: 969500667RSYIH8YL895
FIGI: BBG001V0G683
19 reports from 2012 to 2025